Aviva C. Krauss

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 327 citations · Full text

Medicine, Oncology, Pharmacology +17

Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study

Isaac Yaniv, Aviva C. Krauss, Eric Beohou et al. · Biology of Blood and Marrow Transplantation · 2018 · 74 citations · Full text

Medicine, Hematology, Pediatrics +17

Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors

Meghaan P. Walsh, Brynn B. Duncan, Shannon M. Larabee et al. · PLoS ONE · 2013 · 54 citations · Full text

Medicine, Immunology, Oncology +17

Bone marrow transplantation for non‐malignant diseases using treosulfan‐based conditioning

Yael Dinur‐Schejter, Aviva C. Krauss, Odeya Erlich et al. · Pediatric Blood & Cancer · 2014 · 26 citations

Medicine, Hematology, Pediatrics +14

FDA analysis of pembrolizumab trials in multiple myeloma: Immune related adverse events (irAEs) and response.

Aviva C. Krauss, Flora Mulkey, Yuan-Li Shen et al. · Journal of Clinical Oncology · 2018 · 20 citations

Pharmacy, Oncology, Pharmacotherapy +17